L'utilisation de SGLT2i : un nouveau médicament oral pour le diabète chez le chat

Présenté par Ellen N. Behrend, Ellen N. Behrend, D.M.V., Ph. D., Dipl. ACVIM (médecine interne des animaux de compagnie)

Questionnaire de formation continue

Crédit de formation continue : 1

Nom

Questions

1. Sodium-glucose cotransporter-2 (SGLT-2) is responsible for reabsorbing what percentage of glucose from renal tubules? *
2. What is the main location of sodium-glucose cotransporter 1 (SGLT-1)? *
3. What is glucose toxicity? *
4. The definition of euglycemic diabetic ketoacidosis (EDKA) is the presence of DKA with a blood glucose concentration of: *
5. How is euglycemic DKA treated? *
6. What type of diabetes is thought to be most common in cats? *
7. True or False. When using an SGLT2 inhibitor in a diabetic cat, it is important to pair feeding with drug administration. *
8. Which of the following is a contraindication to using an SGLT2 inhibitor? *
9. True or False. Measuring ketones in serum using a urine dipstick is a more sensitive test for ketosis than measuring ketones in urine using a urine dipstick. *
10. True or False. Use of an SGLT2 inhibitor in a cat with hypersomatotropism/acromegaly is recommended as there is a good chance (70%) the cat will respond to this medication. *